TOKYO -- Japanese technology group NEC has used artificial intelligence to conduct a faster genetic decoding of the novel coronavirus, aiming to accelerate the development of a vaccine to quell the pandemic.
Japanese group conducts genetic analysis, now seeks partners for trials

NEC has joined the ranks of companies searching for a coronavirus vaccine. © Reuters
TOKYO -- Japanese technology group NEC has used artificial intelligence to conduct a faster genetic decoding of the novel coronavirus, aiming to accelerate the development of a vaccine to quell the pandemic.